Search results
Orangutan in the wild applied medicinal plant to heal its own injury, biologists say
NPR· 3 hours ago(Fibraurea tinctoria). It's a type of liana — a vine that climbs into tree canopies to reach...
Earnings call: Tandem Diabetes Care reports growth, new product success
Investing.com· 16 hours agoTandem Diabetes Care (NASDAQ: TNDM ) has announced a solid start to 2024, with worldwide sales...
Tandem Diabetes Care (TNDM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks via Yahoo Finance· 22 hours agoThe headline numbers for Tandem Diabetes Care (TNDM) give insight into how the company performed in...
Novo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 hour agoNovo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript May 2, 2024 Novo Nordisk A/S misses on...
Q1 2024 Tandem Diabetes Care Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 9 hours agoParticipants John F. Sheridan; President, CEO & Director; Tandem Diabetes Care, Inc. Leigh A. Vosseller; Executive VP, CFO & Treasurer; Tandem Diabetes ...
Patients on hunt for diabetes, obesity and weight-loss drugs - Indianapolis Business Journal
Indianapolis Business Journal· 14 hours agoThe phone rings steadily at Phillips Drugs in Richmond these days, with callers asking if the...
‘RHONJ’s Margaret Josephs Speaks Honestly About Ozempic Use
Parade via AOL· 7 hours agoThough countless celebrities have admitted to using the FDA-approved prescription medication for...
Orangutan stuns scientists as it becomes first ever wild animal to treat wound with medicinal plant
UNILAD· 2 hours agoBiologists minds have been blown by Sumatran orangutan Rakus, who healed himself using plants. This...
I Tried Sleeping Tight With Lemme Sleep. Here's What Happened
CNET· 1 hour agoIt’s no secret that sleep is essential to our well-being. Long-term sleep deprivation can have...
Analyst unveils Amgen stock price target after weight-loss drug data
TheStreet via Yahoo Finance· 2 hours agoEli Lilly LLY has seen some impressive results from tirzepatide, which is marketed under two...